Global Vaccine for Influenza Market Growth 2020-2025
COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.
According to this latest study, the 2020 growth of Vaccine for Influenza will have significant change from previous year. By the most conservative estimates of global Vaccine for Influenza market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Vaccine for Influenza market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Vaccine for Influenza market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Vaccine for Influenza, covering the supply chain analysis, impact assessment to the Vaccine for Influenza market size growth rate in several scenarios, and the measures to be undertaken by Vaccine for Influenza companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
For Children (6 months to 3 years)
For Adults and Children over 3 years
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Sanofi
CSL
Mylan
Hulan Bio
GSK
AstraZeneca
CCBIO
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Vaccine for Influenza consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Vaccine for Influenza market by identifying its various subsegments.
Focuses on the key global Vaccine for Influenza manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Vaccine for Influenza with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Vaccine for Influenza submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 What is the Impact of Covid-19 Outbreak On the Vaccine for Influenza?
1.8.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
1.8.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
1.8.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Vaccine for Influenza Market Size in 2020, by Scenario
1.8.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Vaccine for Influenza Consumption 2015-2025
2.1.2 Vaccine for Influenza Consumption CAGR by Region
2.2 Vaccine for Influenza Segment by Type
2.2.1 Trivalent Influenza Vaccine
2.2.2 Quadrivalent Influenza Vaccine
2.3 Vaccine for Influenza Consumption by Type
2.3.1 Global Vaccine for Influenza Consumption Market Share by Type (2015-2020)
2.3.2 Global Vaccine for Influenza Revenue and Market Share by Type (2015-2020)
2.3.3 Global Vaccine for Influenza Sale Price by Type (2015-2020)
2.4 Vaccine for Influenza Segment by Application
2.4.1 For Children (6 months to 3 years)
2.4.2 For Adults and Children over 3 years
2.5 Vaccine for Influenza Consumption by Application
2.5.1 Global Vaccine for Influenza Consumption Market Share by Type (2015-2020)
2.5.2 Global Vaccine for Influenza Value and Market Share by Type (2015-2020)
2.5.3 Global Vaccine for Influenza Sale Price by Type (2015-2020)
3 Global Vaccine for Influenza by Company
3.1 Global Vaccine for Influenza Sales Market Share by Company
3.1.1 Global Vaccine for Influenza Sales by Company (2018-2020)
3.1.2 Global Vaccine for Influenza Sales Market Share by Company (2018-2020)
3.2 Global Vaccine for Influenza Revenue Market Share by Company
3.2.1 Global Vaccine for Influenza Revenue by Company (2018-2020)
3.2.2 Global Vaccine for Influenza Revenue Market Share by Company (2018-2020)
3.3 Global Vaccine for Influenza Sale Price by Company
3.4 Global Vaccine for Influenza Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Vaccine for Influenza Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Vaccine for Influenza Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Vaccine for Influenza by Regions
4.1 Vaccine for Influenza by Regions
4.2 Americas Vaccine for Influenza Consumption Growth
4.3 APAC Vaccine for Influenza Consumption Growth
4.4 Europe Vaccine for Influenza Consumption Growth
4.5 Middle East & Africa Vaccine for Influenza Consumption Growth
5 Americas
5.1 Americas Vaccine for Influenza Consumption by Countries
5.1.1 Americas Vaccine for Influenza Consumption by Countries (2015-2020)
5.1.2 Americas Vaccine for Influenza Value by Countries (2015-2020)
5.2 Americas Vaccine for Influenza Consumption by Type
5.3 Americas Vaccine for Influenza Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Vaccine for Influenza Consumption by Regions
6.1.1 APAC Vaccine for Influenza Consumption by Regions (2015-2020)
6.1.2 APAC Vaccine for Influenza Value by Regions (2015-2020)
6.2 APAC Vaccine for Influenza Consumption by Type
6.3 APAC Vaccine for Influenza Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Vaccine for Influenza by Countries
7.1.1 Europe Vaccine for Influenza Consumption by Countries (2015-2020)
7.1.2 Europe Vaccine for Influenza Value by Countries (2015-2020)
7.2 Europe Vaccine for Influenza Consumption by Type
7.3 Europe Vaccine for Influenza Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Vaccine for Influenza by Countries
8.1.1 Middle East & Africa Vaccine for Influenza Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Vaccine for Influenza Value by Countries (2015-2020)
8.2 Middle East & Africa Vaccine for Influenza Consumption by Type
8.3 Middle East & Africa Vaccine for Influenza Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Vaccine for Influenza Distributors
10.3 Vaccine for Influenza Customer
11 Global Vaccine for Influenza Market Forecast
11.1 Global Vaccine for Influenza Consumption Forecast (2021-2025)
11.2 Global Vaccine for Influenza Forecast by Regions
11.2.1 Global Vaccine for Influenza Forecast by Regions (2021-2025)
11.2.2 Global Vaccine for Influenza Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Vaccine for Influenza Forecast by Type
11.8 Global Vaccine for Influenza Forecast by Application
12 Key Players Analysis
12.1 Sanofi
12.1.1 Company Information
12.1.2 Vaccine for Influenza Product Offered
12.1.3 Sanofi Vaccine for Influenza Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Sanofi Latest Developments
12.2 CSL
12.2.1 Company Information
12.2.2 Vaccine for Influenza Product Offered
12.2.3 CSL Vaccine for Influenza Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 CSL Latest Developments
12.3 Mylan
12.3.1 Company Information
12.3.2 Vaccine for Influenza Product Offered
12.3.3 Mylan Vaccine for Influenza Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Mylan Latest Developments
12.4 Hulan Bio
12.4.1 Company Information
12.4.2 Vaccine for Influenza Product Offered
12.4.3 Hulan Bio Vaccine for Influenza Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Hulan Bio Latest Developments
12.5 GSK
12.5.1 Company Information
12.5.2 Vaccine for Influenza Product Offered
12.5.3 GSK Vaccine for Influenza Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 GSK Latest Developments
12.6 AstraZeneca
12.6.1 Company Information
12.6.2 Vaccine for Influenza Product Offered
12.6.3 AstraZeneca Vaccine for Influenza Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 AstraZeneca Latest Developments
12.7 CCBIO
12.7.1 Company Information
12.7.2 Vaccine for Influenza Product Offered
12.7.3 CCBIO Vaccine for Influenza Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 CCBIO Latest Developments
...
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Vaccine for Influenza Market Size in 2020, by Scenario
Table 2. COVID-19: Measures to be Undertaken by Vaccine for Influenza Companies
Table 3. Research Methodology
Table 4. Data Source
Table 5. Vaccine for Influenza Consumption CAGR by Region 2015-2025 ($ Millions)
Table 6. Major Players of Trivalent Influenza Vaccine
Table 7. Major Players of Quadrivalent Influenza Vaccine
Table 8. Global Consumption Sales by Type (2015-2020)
Table 9. Global Vaccine for Influenza Consumption Market Share by Type (2015-2020)
Table 10. Global Vaccine for Influenza Revenue by Type (2015-2020) ($ million)
Table 11. Global Vaccine for Influenza Value Market Share by Type (2015-2020) ($ Millions)
Table 12. Global Vaccine for Influenza Sale Price by Type (2015-2020)
Table 13. Global Consumption Sales by Application (2015-2020)
Table 14. Global Vaccine for Influenza Consumption Market Share by Application (2015-2020)
Table 15. Global Vaccine for Influenza Value by Application (2015-2020)
Table 16. Global Vaccine for Influenza Value Market Share by Application (2015-2020)
Table 17. Global Vaccine for Influenza Sale Price by Application (2015-2020)
Table 18. Global Vaccine for Influenza Sales by Company (2017-2019) (K Units)
Table 19. Global Vaccine for Influenza Sales Market Share by Company (2017-2019)
Table 20. Global Vaccine for Influenza Revenue by Company (2017-2019) ($ Millions)
Table 21. Global Vaccine for Influenza Revenue Market Share by Company (2017-2019)
Table 22. Global Vaccine for Influenza Sale Price by Company (2017-2019)
Table 23. Global Vaccine for Influenza Manufacturing Base Distribution and Sales Area by Manufacturers
Table 24. Players Vaccine for Influenza Products Offered
Table 25. Vaccine for Influenza Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 26. Global Vaccine for Influenza Consumption by Regions 2015-2020 (K Units)
Table 27. Global Vaccine for Influenza Consumption Market Share by Regions 2015-2020
Table 28. Global Vaccine for Influenza Value by Regions 2015-2020 ($ Millions)
Table 29. Global Vaccine for Influenza Value Market Share by Regions 2015-2020
Table 30. Americas Vaccine for Influenza Consumption by Countries (2015-2020) (K Units)
Table 31. Americas Vaccine for Influenza Consumption Market Share by Countries (2015-2020)
Table 32. Americas Vaccine for Influenza Value by Countries (2015-2020) ($ Millions)
Table 33. Americas Vaccine for Influenza Value Market Share by Countries (2015-2020)
Table 34. Americas Vaccine for Influenza Consumption by Type (2015-2020) (K Units)
Table 35. Americas Vaccine for Influenza Consumption Market Share by Type (2015-2020)
Table 36. Americas Vaccine for Influenza Consumption by Application (2015-2020) (K Units)
Table 37. Americas Vaccine for Influenza Consumption Market Share by Application (2015-2020)
Table 38. APAC Vaccine for Influenza Consumption by Countries (2015-2020) (K Units)
Table 39. APAC Vaccine for Influenza Consumption Market Share by Countries (2015-2020)
Table 40. APAC Vaccine for Influenza Value by Regions (2015-2020) ($ Millions)
Table 41. APAC Vaccine for Influenza Value Market Share by Regions (2015-2020)
Table 42. APAC Vaccine for Influenza Consumption by Type (2015-2020) (K Units)
Table 43. APAC Vaccine for Influenza Consumption Market Share by Type (2015-2020)
Table 44. APAC Vaccine for Influenza Consumption by Application (2015-2020) (K Units)
Table 45. APAC Vaccine for Influenza Consumption Market Share by Application (2015-2020)
Table 46. Europe Vaccine for Influenza Consumption by Countries (2015-2020) (K Units)
Table 47. Europe Vaccine for Influenza Consumption Market Share by Countries (2015-2020)
Table 48. Europe Vaccine for Influenza Value by Countries (2015-2020) ($ Millions)
Table 49. Europe Vaccine for Influenza Value Market Share by Countries (2015-2020)
Table 50. Europe Vaccine for Influenza Consumption by Type (2015-2020) (K Units)
Table 51. Europe Vaccine for Influenza Consumption Market Share by Type (2015-2020)
Table 52. Europe Vaccine for Influenza Consumption by Application (2015-2020) (K Units)
Table 53. Europe Vaccine for Influenza Consumption Market Share by Application (2015-2020)
Table 54. Middle East & Africa Vaccine for Influenza Consumption by Countries (2015-2020) (K Units)
Table 55. Middle East & Africa Vaccine for Influenza Consumption Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Vaccine for Influenza Value by Countries (2015-2020) ($ Millions)
Table 57. Middle East & Africa Vaccine for Influenza Value Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Vaccine for Influenza Consumption by Type (2015-2020) (K Units)
Table 59. Middle East & Africa Vaccine for Influenza Consumption Market Share by Type (2015-2020)
Table 60. Middle East & Africa Vaccine for Influenza Consumption by Application (2015-2020) (K Units)
Table 61. Middle East & Africa Vaccine for Influenza Consumption Market Share by Application (2015-2020)
Table 62. Vaccine for Influenza Distributors List
Table 63. Vaccine for Influenza Customer List
Table 64. Global Vaccine for Influenza Consumption Forecast by Countries (2021-2025) (K Units)
Table 65. Global Vaccine for Influenza Consumption Market Forecast by Regions
Table 66. Global Vaccine for Influenza Value Forecast by Countries (2021-2025) ($ Millions)
Table 67. Global Vaccine for Influenza Value Market Share Forecast by Regions
Table 68. Global Vaccine for Influenza Consumption Forecast by Type (2021-2025) (K Units)
Table 69. Global Vaccine for Influenza Consumption Market Share Forecast by Type (2021-2025)
Table 70. Global Vaccine for Influenza Value Forecast by Type (2021-2025) ($ Millions)
Table 71. Global Vaccine for Influenza Value Market Share Forecast by Type (2021-2025)
Table 72. Global Vaccine for Influenza Consumption Forecast by Application (2021-2025) (K Units)
Table 73. Global Vaccine for Influenza Consumption Market Share Forecast by Application (2021-2025)
Table 74. Global Vaccine for Influenza Value Forecast by Application (2021-2025) ($ Millions)
Table 75. Global Vaccine for Influenza Value Market Share Forecast by Application (2021-2025)
Table 76. Sanofi Product Offered
Table 77. Sanofi Vaccine for Influenza Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 78. Sanofi Main Business
Table 79. Sanofi Latest Developments
Table 80. Sanofi Basic Information, Company Total Revenue (in $ million), Vaccine for Influenza Manufacturing Base, Sales Area and Its Competitors
Table 81. CSL Product Offered
Table 82. CSL Vaccine for Influenza Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 83. CSL Main Business
Table 84. CSL Latest Developments
Table 85. CSL Basic Information, Company Total Revenue (in $ million), Vaccine for Influenza Manufacturing Base, Sales Area and Its Competitors
Table 86. Mylan Product Offered
Table 87. Mylan Vaccine for Influenza Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 88. Mylan Main Business
Table 89. Mylan Latest Developments
Table 90. Mylan Basic Information, Company Total Revenue (in $ million), Vaccine for Influenza Manufacturing Base, Sales Area and Its Competitors
Table 91. Hulan Bio Product Offered
Table 92. Hulan Bio Vaccine for Influenza Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 93. Hulan Bio Main Business
Table 94. Hulan Bio Latest Developments
Table 95. Hulan Bio Basic Information, Company Total Revenue (in $ million), Vaccine for Influenza Manufacturing Base, Sales Area and Its Competitors
Table 96. GSK Product Offered
Table 97. GSK Vaccine for Influenza Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 98. GSK Main Business
Table 99. GSK Latest Developments
Table 100. GSK Basic Information, Company Total Revenue (in $ million), Vaccine for Influenza Manufacturing Base, Sales Area and Its Competitors
Table 101. AstraZeneca Product Offered
Table 102. AstraZeneca Vaccine for Influenza Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 103. AstraZeneca Main Business
Table 104. AstraZeneca Latest Developments
Table 105. AstraZeneca Basic Information, Company Total Revenue (in $ million), Vaccine for Influenza Manufacturing Base, Sales Area and Its Competitors
Table 106. CCBIO Product Offered
Table 107. CCBIO Basic Information, Company Total Revenue (in $ million), Vaccine for Influenza Manufacturing Base, Sales Area and Its Competitors
Table 108. CCBIO Main Business
Table 109. CCBIO Latest Developments
Table 110. CCBIO Vaccine for Influenza Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
List of Figures
Figure 1. Picture of Vaccine for Influenza
Figure 2. Vaccine for Influenza Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Vaccine for Influenza Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Vaccine for Influenza Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Trivalent Influenza Vaccine
Figure 7. Product Picture of Quadrivalent Influenza Vaccine
Figure 8. Global Vaccine for Influenza Consumption Market Share by Type (2015-2020)
Figure 9. Global Vaccine for Influenza Value Market Share by Type (2015-2020)
Figure 10. Vaccine for Influenza Consumed in For Children (6 months to 3 years)
Figure 11. Global Vaccine for Influenza Market: For Children (6 months to 3 years) (2015-2020) (K Units)
Figure 12. Global Vaccine for Influenza Market: For Children (6 months to 3 years) (2015-2020) ($ Millions)
Figure 13. Vaccine for Influenza Consumed in For Adults and Children over 3 years
Figure 14. Global Vaccine for Influenza Market: For Adults and Children over 3 years (2015-2020) (K Units)
Figure 15. Global Vaccine for Influenza Market: For Adults and Children over 3 years (2015-2020) ($ Millions)
Figure 16. Global Vaccine for Influenza Consumption Market Share by Application (2015-2020)
Figure 17. Global Vaccine for Influenza Value Market Share by Application (2015-2020)
Figure 18. Global Vaccine for Influenza Sales Market Share by Company in 2017
Figure 19. Global Vaccine for Influenza Sales Market Share by Company in 2019
Figure 20. Global Vaccine for Influenza Revenue Market Share by Company in 2017
Figure 21. Global Vaccine for Influenza Revenue Market Share by Company in 2019
Figure 22. Global Vaccine for Influenza Sale Price by Company in 2019
Figure 23. Global Vaccine for Influenza Consumption Market Share by Regions 2015-2020
Figure 24. Global Vaccine for Influenza Value Market Share by Regions 2015-2020
Figure 25. Americas Vaccine for Influenza Consumption 2015-2020 (K Units)
Figure 26. Americas Vaccine for Influenza Value 2015-2020 ($ Millions)
Figure 27. APAC Vaccine for Influenza Consumption 2015-2020 (K Units)
Figure 28. APAC Vaccine for Influenza Value 2015-2020 ($ Millions)
Figure 29. Europe Vaccine for Influenza Consumption 2015-2020 (K Units)
Figure 30. Europe Vaccine for Influenza Value 2015-2020 ($ Millions)
Figure 31. Middle East & Africa Vaccine for Influenza Consumption 2015-2020 (K Units)
Figure 32. Middle East & Africa Vaccine for Influenza Value 2015-2020 ($ Millions)
Figure 33. Americas Vaccine for Influenza Consumption Market Share by Countries in 2019
Figure 34. Americas Vaccine for Influenza Value Market Share by Countries in 2019
Figure 35. Americas Vaccine for Influenza Consumption Market Share by Type in 2019
Figure 36. Americas Vaccine for Influenza Consumption Market Share by Application in 2019
Figure 37. United States Vaccine for Influenza Consumption Growth 2015-2020 (K Units)
Figure 38. United States Vaccine for Influenza Value Growth 2015-2020 ($ Millions)
Figure 39. Canada Vaccine for Influenza Consumption Growth 2015-2020 (K Units)
Figure 40. Canada Vaccine for Influenza Value Growth 2015-2020 ($ Millions)
Figure 41. Mexico Vaccine for Influenza Consumption Growth 2015-2020 (K Units)
Figure 42. Mexico Vaccine for Influenza Value Growth 2015-2020 ($ Millions)
Figure 43. APAC Vaccine for Influenza Consumption Market Share by Countries in 2019
Figure 44. APAC Vaccine for Influenza Value Market Share by Regions in 2019
Figure 45. APAC Vaccine for Influenza Consumption Market Share by Type in 2019
Figure 46. APAC Vaccine for Influenza Consumption Market Share by Application in 2019
Figure 47. China Vaccine for Influenza Consumption Growth 2015-2020 (K Units)
Figure 48. China Vaccine for Influenza Value Growth 2015-2020 ($ Millions)
Figure 49. Japan Vaccine for Influenza Consumption Growth 2015-2020 (K Units)
Figure 50. Japan Vaccine for Influenza Value Growth 2015-2020 ($ Millions)
Figure 51. Korea Vaccine for Influenza Consumption Growth 2015-2020 (K Units)
Figure 52. Korea Vaccine for Influenza Value Growth 2015-2020 ($ Millions)
Figure 53. Southeast Asia Vaccine for Influenza Consumption Growth 2015-2020 (K Units)
Figure 54. Southeast Asia Vaccine for Influenza Value Growth 2015-2020 ($ Millions)
Figure 55. India Vaccine for Influenza Consumption Growth 2015-2020 (K Units)
Figure 56. India Vaccine for Influenza Value Growth 2015-2020 ($ Millions)
Figure 57. Australia Vaccine for Influenza Consumption Growth 2015-2020 (K Units)
Figure 58. Australia Vaccine for Influenza Value Growth 2015-2020 ($ Millions)
Figure 59. Europe Vaccine for Influenza Consumption Market Share by Countries in 2019
Figure 60. Europe Vaccine for Influenza Value Market Share by Countries in 2019
Figure 61. Europe Vaccine for Influenza Consumption Market Share by Type in 2019
Figure 62. Europe Vaccine for Influenza Consumption Market Share by Application in 2019
Figure 63. Germany Vaccine for Influenza Consumption Growth 2015-2020 (K Units)
Figure 64. Germany Vaccine for Influenza Value Growth 2015-2020 ($ Millions)
Figure 65. France Vaccine for Influenza Consumption Growth 2015-2020 (K Units)
Figure 66. France Vaccine for Influenza Value Growth 2015-2020 ($ Millions)
Figure 67. UK Vaccine for Influenza Consumption Growth 2015-2020 (K Units)
Figure 68. UK Vaccine for Influenza Value Growth 2015-2020 ($ Millions)
Figure 69. Italy Vaccine for Influenza Consumption Growth 2015-2020 (K Units)
Figure 70. Italy Vaccine for Influenza Value Growth 2015-2020 ($ Millions)
Figure 71. Russia Vaccine for Influenza Consumption Growth 2015-2020 (K Units)
Figure 72. Russia Vaccine for Influenza Value Growth 2015-2020 ($ Millions)
Figure 73. Middle East & Africa Vaccine for Influenza Consumption Market Share by Countries in 2019
Figure 74. Middle East & Africa Vaccine for Influenza Value Market Share by Countries in 2019
Figure 75. Middle East & Africa Vaccine for Influenza Consumption Market Share by Type in 2019
Figure 76. Middle East & Africa Vaccine for Influenza Consumption Market Share by Application in 2019
Figure 77. Egypt Vaccine for Influenza Consumption Growth 2015-2020 (K Units)
Figure 78. Egypt Vaccine for Influenza Value Growth 2015-2020 ($ Millions)
Figure 79. South Africa Vaccine for Influenza Consumption Growth 2015-2020 (K Units)
Figure 80. South Africa Vaccine for Influenza Value Growth 2015-2020 ($ Millions)
Figure 81. Israel Vaccine for Influenza Consumption Growth 2015-2020 (K Units)
Figure 82. Israel Vaccine for Influenza Value Growth 2015-2020 ($ Millions)
Figure 83. Turkey Vaccine for Influenza Consumption Growth 2015-2020 (K Units)
Figure 84. Turkey Vaccine for Influenza Value Growth 2015-2020 ($ Millions)
Figure 85. GCC Countries Vaccine for Influenza Consumption Growth 2015-2020 (K Units)
Figure 86. GCC Countries Vaccine for Influenza Value Growth 2015-2020 ($ Millions)
Figure 87. Global Vaccine for Influenza Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 88. Global Vaccine for Influenza Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 89. Americas Vaccine for Influenza Consumption 2021-2025 (K Units)
Figure 90. Americas Vaccine for Influenza Value 2021-2025 ($ Millions)
Figure 91. APAC Vaccine for Influenza Consumption 2021-2025 (K Units)
Figure 92. APAC Vaccine for Influenza Value 2021-2025 ($ Millions)
Figure 93. Europe Vaccine for Influenza Consumption 2021-2025 (K Units)
Figure 94. Europe Vaccine for Influenza Value 2021-2025 ($ Millions)
Figure 95. Middle East & Africa Vaccine for Influenza Consumption 2021-2025 (K Units)
Figure 96. Middle East & Africa Vaccine for Influenza Value 2021-2025 ($ Millions)
Figure 97. United States Vaccine for Influenza Consumption 2021-2025 (K Units)
Figure 98. United States Vaccine for Influenza Value 2021-2025 ($ Millions)
Figure 99. Canada Vaccine for Influenza Consumption 2021-2025 (K Units)
Figure 100. Canada Vaccine for Influenza Value 2021-2025 ($ Millions)
Figure 101. Mexico Vaccine for Influenza Consumption 2021-2025 (K Units)
Figure 102. Mexico Vaccine for Influenza Value 2021-2025 ($ Millions)
Figure 103. Brazil Vaccine for Influenza Consumption 2021-2025 (K Units)
Figure 104. Brazil Vaccine for Influenza Value 2021-2025 ($ Millions)
Figure 105. China Vaccine for Influenza Consumption 2021-2025 (K Units)
Figure 106. China Vaccine for Influenza Value 2021-2025 ($ Millions)
Figure 107. Japan Vaccine for Influenza Consumption 2021-2025 (K Units)
Figure 108. Japan Vaccine for Influenza Value 2021-2025 ($ Millions)
Figure 109. Korea Vaccine for Influenza Consumption 2021-2025 (K Units)
Figure 110. Korea Vaccine for Influenza Value 2021-2025 ($ Millions)
Figure 111. Southeast Asia Vaccine for Influenza Consumption 2021-2025 (K Units)
Figure 112. Southeast Asia Vaccine for Influenza Value 2021-2025 ($ Millions)
Figure 113. India Vaccine for Influenza Consumption 2021-2025 (K Units)
Figure 114. India Vaccine for Influenza Value 2021-2025 ($ Millions)
Figure 115. Australia Vaccine for Influenza Consumption 2021-2025 (K Units)
Figure 116. Australia Vaccine for Influenza Value 2021-2025 ($ Millions)
Figure 117. Germany Vaccine for Influenza Consumption 2021-2025 (K Units)
Figure 118. Germany Vaccine for Influenza Value 2021-2025 ($ Millions)
Figure 119. France Vaccine for Influenza Consumption 2021-2025 (K Units)
Figure 120. France Vaccine for Influenza Value 2021-2025 ($ Millions)
Figure 121. UK Vaccine for Influenza Consumption 2021-2025 (K Units)
Figure 122. UK Vaccine for Influenza Value 2021-2025 ($ Millions)
Figure 123. Italy Vaccine for Influenza Consumption 2021-2025 (K Units)
Figure 124. Italy Vaccine for Influenza Value 2021-2025 ($ Millions)
Figure 125. Russia Vaccine for Influenza Consumption 2021-2025 (K Units)
Figure 126. Russia Vaccine for Influenza Value 2021-2025 ($ Millions)
Figure 127. Spain Vaccine for Influenza Consumption 2021-2025 (K Units)
Figure 128. Spain Vaccine for Influenza Value 2021-2025 ($ Millions)
Figure 129. Egypt Vaccine for Influenza Consumption 2021-2025 (K Units)
Figure 130. Egypt Vaccine for Influenza Value 2021-2025 ($ Millions)
Figure 131. South Africa Vaccine for Influenza Consumption 2021-2025 (K Units)
Figure 132. South Africa Vaccine for Influenza Value 2021-2025 ($ Millions)
Figure 133. Israel Vaccine for Influenza Consumption 2021-2025 (K Units)
Figure 134. Israel Vaccine for Influenza Value 2021-2025 ($ Millions)
Figure 135. Turkey Vaccine for Influenza Consumption 2021-2025 (K Units)
Figure 136. Turkey Vaccine for Influenza Value 2021-2025 ($ Millions)
Figure 137. GCC Countries Vaccine for Influenza Consumption 2021-2025 (K Units)
Figure 138. GCC Countries Vaccine for Influenza Value 2021-2025 ($ Millions)
Figure 139. Sanofi Vaccine for Influenza Market Share (2018-2020)
Figure 140. CSL Vaccine for Influenza Market Share (2018-2020)
Figure 141. Mylan Vaccine for Influenza Market Share (2018-2020)
Figure 142. Hulan Bio Vaccine for Influenza Market Share (2018-2020)
Figure 143. GSK Vaccine for Influenza Market Share (2018-2020)
Figure 144. AstraZeneca Vaccine for Influenza Market Share (2018-2020)
Figure 145. CCBIO Vaccine for Influenza Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets